Showing results (1851-1860 of 12,123) with videos related to
Sort By:
Pageof 1,213
Neuropharmacology|July 1, 1986
Evaluation of the role of antinociception in self-injurious behavior following intranigral injection of muscimolG D Frye, A A Baumeister, K Crotty, et al.Neuropharmacology|July 1, 1986
Hypertension and tachycardia produced by inhibition of reuptake of 5-hydroxytryptamine by fluoxetine in the ratM L Tsai, M T LinNeuropharmacology|December 12, 2017
Endogenous dopamine and endocannabinoid signaling mediate cocaine-induced reversal of AMPAR synaptic potentiation in the nucleus accumbens shellAnna E Ingebretson, Matthew C Hearing, Ethan D Huffington, et al.Neuropharmacology|December 24, 2017
Progress in understanding mechanisms of opioid-induced gastrointestinal adverse effects and respiratory depressionMohammad Zafar Imam, Andy Kuo, Sussan Ghassabian, et al.Neuropharmacology|February 24, 2018
Direct evidence for high affinity blockade of NaV1.6 channel subtype by huwentoxin-IV spider peptide, using multiscale functional approachesTânia C Gonçalves, Rachid Boukaiba, Jordi Molgó, et al.Neuropharmacology|October 1, 1986
5-Hydroxytryptamine and noradrenaline uptake inhibition: studies on sleep in manA N Nicholson, P A PascoeNeuropharmacology|March 5, 2018
Retigabine ameliorates acute stress-induced impairment of spatial memory retrieval through regulating USP2 signaling pathways in hippocampal CA1 areaCai Li, Ji Zhang, Haiwei Xu, et al.Neuropharmacology|March 6, 2018
Deep brain stimulation and fluoxetine exert different long-term changes in the serotonergic systemJulien Volle, Tatiana Bregman, Brian Scott, et al.Neuropharmacology|March 6, 2018
Thrombolytic therapies for ischemic stroke: Triumphs and future challengesAimen Moussaddy, Andrew M Demchuk, Michael D HillNeuropharmacology|March 6, 2018
Toll-like receptor 3 activation impairs excitability and synaptic activity via TRIF signalling in immature rat and human neuronsLouise Ritchie, Rothwell Tate, Luke H Chamberlain, et al.Pageof 1,213